mCRC Myth-Busters reloaded: More facts for optimal patient benefit!

Merck-sponsored Satellite Symposium held in conjunction with the ESMO 18th World Congress on Gastrointestinal Cancer:

Chair: Claus-Henning Köhne (Oldenburg, Germany

  • Claus-Henning - Introducing the current mCRC Myth-Busters:

 

  • Wolff Schmiegel, Bochum, Germany: Innovation in biomarker detection: What are the opportunities for clinical practice? 
    SLIDES

 

  • Alfredo Falcone, Pisa, Italy: Treatment goals: What should we be aiming for? 
    SLIDES

 

  • Julien Taïeb, Paris, France: Ensuring patients get the most out of their treatment: What is the best approach? 
    SLIDES

 

  • Claus-Henning Köhne: Summary and statement:
    SLIDES